- Author:
Yao-Long CHEN
1
;
Chen ZHAO
2
;
Li ZHANG
3
;
Bo LI
4
;
Chuan-Hong WU
5
;
Wei MU
3
;
Jia-Ying WANG
6
;
Ke-Hu YANG
7
;
You-Ping LI
8
;
Chiehfeng CHEN
9
;
Yong-Yan WANG
10
;
Chen WANG
11
;
Zhao-Xiang BIAN
2
;
Hong-Cai SHANG
12
Author Information
- Publication Type:Journal Article
- Keywords: Chinese medicine; clinical practice guidelines; evidence-based medicine; randomized controlled trial; systematic review
- MeSH: Critical Pathways; Evidence-Based Medicine; Humans; Medicine, Chinese Traditional; Practice Guidelines as Topic; Randomized Controlled Trials as Topic
- From: Chinese journal of integrative medicine 2018;24(3):163-170
- CountryChina
- Language:English
- Abstract: How to test the treatments of Chinese medicine (CM) and make them more widely accepted by practitioners of Western medicine and the international healthcare community is a major concern for practitioners and researchers of CM. For centuries, various approaches have been used to identify and measure the efficacy and safety of CM. However, the high-quality evidence related to CM that produced in China is still rare. Over the recent years, evidence-based medicine (EBM) has been increasingly applied to CM, strengthening its theoretical basis. This paper reviews the past and present state of CM, analyzes the status quo, challenges and opportunities of basic research, clinical trials, systematic reviews, clinical practice guidelines and clinical pathways and evidence-based education developed or conducted in China, pointing out how EBM can help to make CM more widely used and recognized worldwide.